RENATTIE PERRY: Open Payments
NPI 1407182926 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$487 in 20 payments from 6 companies in 2025. Trend: 2023 $461 · 2024 $749 · 2025 $487
Food & beverage: $487
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $255 |
| Supernus Pharmaceuticals, Inc. | 2 | $140 |
| Lundbeck LLC | 2 | $32 |
| Neurocrine BioSciences, Inc. | 2 | $28 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: VRAYLAR, Qelbree, REXULTI, INGREZZA, TRINTELLIX.
Industry payments across OH — which companies pay providers there.
